Mycoprotein Patents: Who Leads, Where the Gaps Are 2026
- One filer holds 161 of 299 records in scope, with the top five combined at 75.3% — this field is concentrated, not fragmented.
- Filings fell 44% from 2021 to 2024 (39 to 22), the last two years with a complete publication window, after peaking at 87 in 2022.
- C12N microorganism and genetic engineering claims cover 65.6% of records, while animal feed (A23K) and water treatment (C02F) sit well under 15% each.
Filing growth compares 2021 (39 records) with 2024 (22) — a three-year span. 2024 is the most recent year we treat as complete: publication lags filing by roughly 18 months, so 2025 onwards are still filling in and any growth rate that ends there would understate the field. Top-5 share is the combined record count of the five largest assignees divided by all 299 records in scope (CR5), not by the ranked leaders only.
What the mycoprotein patent record shows
Mycoprotein and fungal biomass patenting spans strain engineering, submerged fermentation process control, and downstream texturisation for food applications. The 299 records in scope run from 2015 through the 2026 cut-off, with publication activity concentrated in the fermentation and microbial-genetics classes rather than in feed or wastewater applications. Family-level counting is used throughout so that continuations and multi-jurisdiction refiling of the same invention are not counted twice.
Filing activity peaked in 2022 and has since declined through the last complete year, 2024 — a pattern consistent with an early wave of platform and strain claims giving way to a smaller set of process-refinement filings. Publication lags filing by roughly 18 months, so 2025 and 2026 figures will fill in as later data becomes available and should not yet be read as a slowdown.
Filing trends and technology composition
Annual filing counts and IPC subclass distribution across the 299 records in scope, drawn from the same dataset used throughout this page.
A concentrated filing wave, now cooling from its 2022 peak
Filings rose from 52 in 2017 to a peak of 87 in 2022, then fell to 22 by 2024 — a 44% decline over the 2021-2024 span. Because publication trails filing by about 18 months, the 2025-2026 counts are still incomplete and should not be read as confirming a continued drop.
Fermentation and microbial genetics dominate the claim space
C12N (microorganisms and genetic engineering) appears in 65.6% of the 299 records, followed by A23L food applications at 50.5% and A23J protein/peptide claims at 40.8%. Feed (A23K) and wastewater treatment (C02F) each sit near 12%, marking them as the smaller, less-crowded branches of this dataset.
Shares are the percentage of the 299 records in scope. A patent can carry several IPC classes, so the shares add up to more than 100%.
Go deeper on Mycoprotein and Fungal Biomass with Eureka
This page is one run against one query. Ask Eureka your own question about mycoprotein and fungal biomass and every answer comes back with the patent numbers behind it.
Try EurekaThe most-cited filings and the newest published claim
WO2026132133A1 — Bioreactor for producing mycoprotein and method of operating such bioreactor
A bioreactor for producing a protein, such as a mycoprotein and/or mycelium fibers, is proposed. The reactor body has a reactor wall confining a volume for incubating an inoculum, with a tapering bottom section, a bottom opening, and a cap covering that opening. The cap includes a top face and a first fluid channel extending through it, configured to transfer fluid between the inside of the reactor and the cap assembly.Published 2026-06-25 by Pacifico Biolabs GmbH — filed at the very edge of the coverage window, so downstream citation activity has not yet had time to accumulate.
| # | Publication no. | Patent title | Citations |
|---|---|---|---|
| 1 | WO2017151684A1 | Filamentous fungal biomats, methods of their production and methods of their use | 102 |
| 2 | US20200268031A1 | Food Materials Comprising Filamentous Fungal Particles and Membrane Bioreactor Design | 52 |
| 3 | CN102210383A | 利用马铃薯加工后的废水、废渣制备菌体蛋白饲料的方法 | 35 |
| 4 | US10590379B2 | Filamentous fungal biomats, methods of their production and methods of their use | 23 |
| 5 | US10577579B2 | Filamentous fungal biomats, methods of their production and methods of their use | 23 |
| 6 | US10533155B2 | Filamentous fungal biomats, methods of their production and methods of their use | 23 |
| 7 | US20210017486A1 | Filamentous fungal biomats, methods of their production and methods of their use | 19 |
| 8 | US20200095535A1 | Filamentous fungal biomats, methods of their production and methods of their use | 19 |
| 9 | US20050272129A1 | Transgenic fungi expressing Bcl-2 and methods of using Bcl-2 or portions thereof for improving biomass produc… | 19 |
| 10 | US20190040352A1 | Filamentous fungal biomats, methods of their production and methods of their use | 18 |
Citation counts reflect activity within this searched corpus and skew toward older, earlier-published filings; treat them as a signal of influence rather than current relevance.
Patent titles are shown in the language they were filed in, not translated, so that each record stays verifiable against the original filing — a translated title will not match in Eureka or in any national register. Each row carries its publication number; clicking a row searches Eureka by that number.
Put your own technology through the same analysis
Eureka on the web
When you want the answer in the next five minutes.
The agent works the prompt against patents and technical literature, citing every source.
Run your analysis now →MCP server & REST API
When it has to run inside your own pipeline.
Patent search, landscape analysis and assignee resolution as MCP tools. Drop them into any agent framework, or call REST directly.
Browse MCP servers →What the numbers mean for a filing decision
Three patterns stand out once the raw counts are set against their denominators: concentration at the top, a cooling filing wave, and an IPC mix that is heavily skewed toward upstream microbiology rather than downstream applications.
A small group holds most of the claim space
The leading assignee alone accounts for 161 of the 299 records in scope, and the top five combined reach 75.3%. A field this concentrated leaves little room for a new entrant to claim broad process or strain territory without designing carefully around existing filings.
The 2022 peak has not been sustained
Filings dropped from 39 in 2021 to 22 in 2024, after peaking at 87 in 2022. That is a real three-year decline in the last fully-published years, though 2025-2026 counts are still incomplete due to the normal 18-month publication lag and should not be read as evidence of a continued fall.
Upstream microbiology dominates over downstream application claims
C12N claims cover almost two-thirds of records, while A23K animal feed and C02F wastewater treatment each sit near 12%. That gap suggests most inventive effort has gone into the organism and fermentation process itself rather than into feed-grade or effluent-stream applications of the same biomass.
Eureka can read the same corpus for gaps instead of for coverage: under-claimed branches adjacent to mycoprotein and fungal biomass, with the prior art for and against each one.
Who holds the claim space, and where activity has gone quiet
The 43 ranked assignees are the entire set the data endpoint returns for this dataset — not a top-50 or top-100 cut. Recent-year momentum shows the leading names filing nothing in the latest tracked year, consistent with the broader 2021-2024 decline rather than a single company pulling back.
One company anchors more than half the field
With 161 of 299 records, the leading assignee's filings alone shape much of the available claim space in fermentation and strain process work. Their recent-year momentum shows zero new filings in the latest tracked year, a pattern shared across the other leading names.
Collaboration is limited and concentrated around one hub
Only 10 co-assignee pairs appear across the dataset, and the strongest pairings all involve the same leading company working with a small number of named individuals or a single corporate partner. Most other assignees file independently.
The leading names have gone quiet in the most recent tracked year
Every assignee named in recent-year momentum data — including the top filer — shows zero filings in the latest year, with year-over-year drops of -100% where a comparison is available. Given the 18-month publication lag, this likely reflects incomplete data rather than an actual halt in R&D.
| Assignee | Recent year | YoY |
|---|---|---|
| The Fynder Group Inc | 0 | -100% |
| Aquacultured Foods Inc | 0 | — |
| THE PROTEIN BREWERY BV | 0 | — |
| AQUACULTURED FOODS INC | 0 | — |
| MYCORENA AB | 0 | — |
| Millow Hldg AB | 0 | -100% |
| MILLOW HLDG AB | 0 | — |
| MycoTechnology Inc | 0 | — |
Where to take this analysis
The dataset points to a field where upstream microbiology is heavily claimed but several downstream and adjacent branches remain comparatively open.
Map freedom-to-operate against the leading filer
With one assignee holding 161 of 299 records, any new fermentation or strain-engineering filing should be checked claim-by-claim against that portfolio before drafting.
Run a freedom-to-operate check in EurekaWatch the under-claimed branches
Feed-grade formulations, wastewater-substrate recovery, and texture-fibre engineering each carry far fewer records than the C12N/A23L core, and may offer more defensible first-claim territory.
Explore white space in EurekaTrack filings past the publication lag
Because 2025-2026 counts are still incomplete, monitoring newly published filings as they clear the 18-month lag will show whether the 2021-2024 decline continues or reverses.
Set up filing alerts in EurekaCommon questions about mycoprotein patents
One assignee holds 161 of the 299 records in scope, making it the clear leader by a wide margin. The top five assignees combined account for 75.3% of all records, so the field is concentrated rather than evenly spread across many filers. The ranking covers 43 companies in total, which is the complete set returned for this dataset rather than a top-50 or top-100 cut.
Filings peaked at 87 in 2022 and fell to 22 by 2024, a 44% decline from the 2021 level of 39. That drop covers the most recent years that can be treated as fully published. 2025 and 2026 counts are still incomplete because publication typically lags filing by about 18 months, so it is too early to call the current trajectory a permanent slowdown.
The dataset is dominated by C12N microorganism and genetic-engineering claims, appearing in 65.6% of the 299 records, followed by A23L food-application claims at 50.5% and A23J protein/peptide claims at 40.8%. Animal feed (A23K) and wastewater treatment (C02F) each sit near 12%, marking them as comparatively under-claimed relative to the fermentation and food-application core. A single record can carry multiple IPC classes, which is why these shares add to more than 100%.
The branches furthest from the dense core are feed-grade biomass formulations, wastewater-substrate feedstock recovery, texture-fibre engineering for whole-cut food analogues, and bioreactor harvesting hardware — each represented by materially fewer records than the C12N/A23L cluster. These are not guaranteed to be empty, but they carry lower filing density than the fermentation and strain-engineering core, which is where most of the top assignee's portfolio sits. A freedom-to-operate check against the leading filer's specific claims is still necessary before assuming open space.
The newest published filing in this dataset, WO2026132133A1 from Pacifico Biolabs GmbH, published 2026-06-25, describes a bioreactor for producing mycoprotein and mycelium fibers. Its claims centre on a reactor body with a tapering bottom section, a bottom opening, and a cap containing a fluid channel for transferring fluid between the reactor interior and the cap assembly. Because it published at the very edge of the coverage window, it has not yet accumulated citation activity, so its downstream influence cannot yet be assessed from this dataset.
Research Mycoprotein and Fungal Biomass in depth with Eureka
Go past this page: query the whole mycoprotein and fungal biomass corpus yourself, in your own scope.
Every answer comes back with patent numbers you can open.
Disclaimer. This page is generated from Patsnap Eureka data drawn from a limited snapshot of global patent and scientific-literature records, and is provided for general information and reference only.
Patent data carries inherent limitations: recent filings (typically the most recent 18–24 months) are under-counted due to standard publication lag; counts may be reported at either a patent-family or a patent-record basis and are not always directly comparable; classification, applicant-name, and citation data may contain errors, duplicates, or omissions; and the underlying search query defines and constrains the scope shown. As a result, the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing on this page constitutes an exhaustive prior-art, novelty, freedom-to-operate, or validity search, nor does it constitute legal, financial, investment, or professional advice, and it should not be relied upon as such. Any patent, commercial, or strategic decision should be verified independently and reviewed with qualified patent, legal, and domain professionals. Patsnap makes no warranties, express or implied, as to the accuracy, completeness, or fitness for any particular purpose of the information presented.
Machine translation. Assignee and organisation names originally recorded in Chinese, Japanese or Korean have been rendered into English by an AI translation step so that the tables stay readable. These renderings are best-effort and may not match a company’s registered English name; the original name is what the underlying patent record carries, and it is what any Eureka query launched from this page uses.